Autopsy report · NCT00816166
VISSIT Intracranial Stent Study for Ischemic Therapy
Cause of deathNo reason given
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 5 years 8 months before it stopped.
- 125 participants enrolled.
- Results were posted on the registry 0 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Codman & Shurtleff
- Sponsor type
- Industry
- Conditions
- Ischemic Stroke; Transient Ischemic Attack
- Interventions
- Pharos Vitesse Neurovascular Stent System (Stent implantation) + Medical therapy (Aspirin and Clopidogrel); Aspirin and Clopidogrel (Medical therapy)
- Participants
- 125
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.